Trends in solubility of polymorphs

被引:385
作者
Pudipeddi, M [1 ]
Serajuddin, ATM [1 ]
机构
[1] Nova Pharmaceut Corp, E Hanover, NJ 07936 USA
关键词
solubility; polymorphs;
D O I
10.1002/jps.20302
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Polymorphism of drug substances has been the subject of intense investigation in the pharmaceutical field for over 40 years. Considering the multitude of reports on solubility or dissolution of polymorphs in the literature, an attempt is made in this study to answer the question: How big is the impact of polymorphism on solubility? A large number of literature reports on solubility or dissolution of polymorphs were reviewed and the data were analyzed for trends in solubility ratio of polymorphs. The general trend reveals that the ratio of polymorph solubility is typically less than 2, although occasionally higher ratios can be observed. A similar trend is also observed for anhydrate/hydrate solubility ratios, although anhydrate/hydrate solubility ratios appear to be more spread out and higher than the typical ratio for nonsolvated polymorphs. An attempt is also made in this commentary to estimate the ratio of solubilities of polymorphs from thermal data. The trend in estimated solubility ratio shows good agreement with the one observed with experimentally determined solubility values. (c) 2005 Wiley-Liss, Inc. and the American Pharmacists Association.
引用
收藏
页码:929 / 939
页数:11
相关论文
共 72 条
[11]   SOLID-STATE NMR AND IR FOR THE ANALYSIS OF PHARMACEUTICAL SOLIDS - POLYMORPHS OF FOSINOPRIL SODIUM [J].
BRITTAIN, HG ;
MORRIS, KR ;
BUGAY, DE ;
THAKUR, AB ;
SERAJUDDIN, ATM .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1993, 11 (11-12) :1063-1069
[12]  
Brittain HG, 1999, DRUGS PHARM SCI, V95, P279
[13]   Polymorphism and preformulation studies of lifibrol [J].
Burger, A ;
Lettenbichler, A .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 49 (01) :65-72
[14]  
BURGER A, 1993, PHARMAZIE, V48, P262
[15]  
Burnette RR, 2000, J PHARM SCI, V89, P1389
[16]   PHARMACEUTICAL SOLIDS - A STRATEGIC APPROACH TO REGULATORY CONSIDERATIONS [J].
BYRN, S ;
PFEIFFER, R ;
GANEY, M ;
HOIBERG, C ;
POOCHIKIAN, G .
PHARMACEUTICAL RESEARCH, 1995, 12 (07) :945-954
[17]  
BYRN SR, 1999, SOLID STATE CHEM DRU, P143
[18]   Structural characterization, physicochemical properties, and thermal stability of three crystal forms of nifedipine [J].
Caira, MR ;
Robbertse, Y ;
Bergh, JJ ;
Song, MN ;
De Villiers, MM .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (12) :2519-2533
[19]   Solid phases of tenoxicam [J].
Cantera, RG ;
Leza, MG ;
Bachiller, CM .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (10) :2240-2251
[20]   Preparation and characterization of polymorphs for an LTD(4) antagonist, RG 12525 [J].
Carlton, RA ;
Difeo, TJ ;
Powner, TH ;
Santos, I ;
Thompson, MD .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (05) :461-467